5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 13.35▼ | 13.36▼ | 13.38▼ | 13.21▲ | 12.91▲ |
MA10 | 13.37▼ | 13.38▼ | 13.26▲ | 13.00▲ | 12.85▲ |
MA20 | 13.37▼ | 13.18▲ | 13.09▲ | 13.05▲ | 13.02▲ |
MA50 | 13.23▲ | 13.13▲ | 12.92▲ | 12.89▲ | 14.56▼ |
MA100 | 13.11▲ | 12.90▲ | 13.12▲ | 13.22▲ | 10.63▲ |
MA200 | 12.93▲ | 13.11▲ | 13.08▲ | 15.15▼ | 7.65▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.017▼ | 0.010▲ | 0.031▲ | 0.004▲ | 0.048▲ |
RSI | 47.259▼ | 54.033▲ | 55.012▲ | 53.110▲ | 48.466▼ |
STOCH | 33.172 | 50.955 | 81.877▲ | 48.412 | 52.732 |
WILL %R | -93.750▼ | -40.517 | -26.111 | -55.903 | -31.693 |
CCI | -63.392 | 9.721 | 52.100 | 30.930 | 76.476 |
Monday, August 04, 2025 11:10 AM
Key Insights Institutions' substantial holdings in LifeVantage implies that they have significant influence over ...
|
Thursday, July 24, 2025 05:11 AM
Launch delivers innovative business opportunity and top wellness products to Iceland, marking a bold step in European expansionSALT LAKE CITY, July 24, 2025 (GLOBE NEWSWIRE) -- LifeVantage ...
|
Tuesday, July 22, 2025 06:00 AM
SALT LAKE CITY, July 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (LFVN) (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 13.30 | 13.58 | 13.0629 | 13.30 | 60,455 |
07/08/25 | 13.09 | 13.205 | 12.566 | 13.09 | 67,422 |
06/08/25 | 13.50 | 13.52 | 12.84 | 12.94 | 76,808 |
05/08/25 | 13.40 | 13.4799 | 12.9495 | 13.44 | 58,928 |
04/08/25 | 12.70 | 13.31 | 12.67 | 13.29 | 69,369 |
01/08/25 | 12.40 | 12.62 | 12.1011 | 12.58 | 64,103 |
31/07/25 | 12.64 | 12.73 | 12.34 | 12.55 | 92,241 |
30/07/25 | 12.95 | 13.13 | 12.51 | 12.72 | 84,980 |
29/07/25 | 13.14 | 13.18 | 12.83 | 12.91 | 77,430 |
28/07/25 | 13.87 | 13.87 | 13.10 | 13.13 | 72,715 |
|
|
||||
|
|
||||
|
|